Comparative In-Vitro Quality Assessment of Commercially Available Isosorbide Dinitrate 10 mg Tablet Formulations
Isosorbide dinitrate (ISDN) is a well-known organic nitrate that is frequently used to treat heart failure and angina pectoris because of its potent vasodilatory activity. The pharmacological profile, mechanisms of action, therapeutic uses, and new developments in formulation techniques are the main topics of this review article's thorough assessment of ISDN. The medication's effects on nitric oxide pathway modulation, myocardial oxygen supply-demand balance, and preload and afterload reduction in cardiovascular diseases are highlighted. The article also discusses safety concerns and limitations such as tolerance development, and clinical evidence for its effectiveness. In order to improve therapeutic results, novel therapeutic strategies including combination regimens and medication administration are also covered. Overall, this review highlights the ongoing importance of ISDN in cardiovascular medication and suggests possible avenues for further study and therapeutic application.
Authors
- Naga Santhosh Reddy Satti
- Veerendra Kumar D
- Sai Sri Mounika Tanapathi
- Bunny Nuthulapati
- Sri Satya Ratna Navya Lakshmi Chakka
- Varshitha Satti
Publication Details
- Journal
- International Journal of Pharmaceutics and Drug Analysis
- Published
- 2026-11-13
- DOI
- https://doi.org/10.47957/ijpda.v14i3.758
- Primary Topic
- Analytical Methods in Pharmaceuticals
- Type
- article
- Field-Weighted Citation Impact
- 0.00